UNSPSC 85921007: Pharmacotherapy for substance abuse treatment, antabuse

This classification denotes the group of activities that yields a substance abuse treatment intervention or procedure of pharmacotherapy for substance abuse treatment, antabusepharmacotherapy for substance abuse treatment, antabuse. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code HZ93ZZZ

UNSPSC 85921007 Pharmacotherapy for substance abuse treatment, antabuse is a Commodity code, but the recent state and local opportunities tagged under this code do not substantively reflect pharmacotherapy or antabuse procurement. Instead, the opportunities show a pronounced mismatch: the tagged records include speech-language pathology staffing (Hillsborough County Public Schools), substance abuse treatment and cognitive interventions for offenders (Harris County Community Supervision & Corrections), cellular therapy lab software (UT Health San Antonio), rehabilitation outcome measurement services (San Mateo County), special education managed staffing (Griffin-Spalding County Schools), and psychology-based crisis services (Phoenix Police Department). None of these align with the procurement of antabuse or pharmacotherapy products for substance abuse treatment. The code shows little relevant recent activity, and the tagged opportunities appear to reflect categorization error or system tagging artifacts rather than legitimate commodity-level demand for antabuse or related pharmacotherapeutic agents under this UNSPSC classification.

State and local procurement offices are not currently buying antabuse or comparable pharmacotherapy for substance abuse treatment under this code in the recent record. Business development professionals should treat this code as inactive for substance abuse pharmacotherapy procurement and validate coding manually before pursuing opportunities tagged to UNSPSC 85921007.